# Burke & Herbert Financial Services Corp.: financial statements, quarterly

BHRB · Nasdaq · CIK 1964333 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bhrb.md) · [Financials](/companies/bhrb/financials.md) · [Filings](/companies/bhrb/filings.md) · [Insiders](/companies/bhrb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bhrb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [14.4](/filings/0001964333-23-000213.md) | [15.9 d](/filings/0001964333-24-000079.md) | [16.6](/filings/0001964333-24-000219.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.5](/filings/0001964333-24-000363.md) | [0.5 d](/filings/0001964333-26-000016.md) | [0.7](/filings/0001964333-25-000180.md) | [(2.2)](/filings/0001964333-25-000231.md) | [5.2](/filings/0001964333-25-000245.md) | [0.5 d](/filings/0001964333-26-000016.md) | [5.6](/filings/0001964333-26-000068.md) | [7.3](/filings/0001964333-26-000095.md) | [7.0](/filings/0001964333-25-000245.md) | [7.7 d](/filings/0001964333-26-000016.md) | [6.0](/filings/0001964333-26-000068.md) | [2.5](/filings/0001964333-26-000095.md) |
| Net income | $m | [4.1](/filings/0001964333-24-000363.md) | [5.1 d](/filings/0001964333-26-000016.md) | [5.2](/filings/0001964333-25-000180.md) | [(16.9)](/filings/0001964333-25-000231.md) | [27.6](/filings/0001964333-25-000245.md) | [19.8 d](/filings/0001964333-26-000016.md) | [27.2](/filings/0001964333-26-000068.md) | [29.9](/filings/0001964333-26-000095.md) | [30.0](/filings/0001964333-25-000245.md) | [30.2 d](/filings/0001964333-26-000016.md) | [27.3](/filings/0001964333-26-000068.md) | [9.5](/filings/0001964333-26-000095.md) |
| Diluted EPS | $ per share | [0.55](/filings/0001964333-24-000363.md) | not reported | [0.69](/filings/0001964333-25-000180.md) | [(1.41)](/filings/0001964333-25-000231.md) | [1.82](/filings/0001964333-25-000245.md) | not reported | [1.80](/filings/0001964333-26-000068.md) | [1.97](/filings/0001964333-26-000095.md) | [1.97](/filings/0001964333-25-000245.md) | not reported | [1.79](/filings/0001964333-26-000068.md) | [0.50](/filings/0001964333-26-000095.md) |
| Basic EPS | $ per share | [0.55](/filings/0001964333-24-000363.md) | not reported | [0.70](/filings/0001964333-25-000180.md) | [(1.41)](/filings/0001964333-25-000231.md) | [1.83](/filings/0001964333-25-000245.md) | not reported | [1.80](/filings/0001964333-26-000068.md) | [1.98](/filings/0001964333-26-000095.md) | [1.98](/filings/0001964333-25-000245.md) | not reported | [1.80](/filings/0001964333-26-000068.md) | [0.50](/filings/0001964333-26-000095.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $bn | [3.6](/filings/0001964333-23-000213.md) | [3.6](/filings/0001964333-25-000105.md) | [3.7](/filings/0001964333-24-000219.md) | [7.8](/filings/0001964333-24-000316.md) | [7.9](/filings/0001964333-24-000363.md) | [7.8](/filings/0001964333-26-000016.md) | [7.8](/filings/0001964333-25-000180.md) | [8.1](/filings/0001964333-25-000231.md) | [7.9](/filings/0001964333-25-000245.md) | [7.9](/filings/0001964333-26-000095.md) | [7.9](/filings/0001964333-26-000068.md) | [11.0](/filings/0001964333-26-000095.md) |
| Total liabilities | $bn | [3.3](/filings/0001964333-23-000213.md) | [3.3](/filings/0001964333-25-000105.md) | [3.4](/filings/0001964333-24-000219.md) | [7.1](/filings/0001964333-24-000316.md) | [7.1](/filings/0001964333-24-000363.md) | [7.1](/filings/0001964333-26-000016.md) | [7.1](/filings/0001964333-25-000180.md) | [7.3](/filings/0001964333-25-000231.md) | [7.1](/filings/0001964333-25-000245.md) | [7.1](/filings/0001964333-26-000095.md) | [7.1](/filings/0001964333-26-000068.md) | [9.8](/filings/0001964333-26-000095.md) |
| Short-term borrowings | $bn | not reported | [0.3](/filings/0001964333-25-000105.md) | not reported | [0.3](/filings/0001964333-24-000316.md) | [0.3](/filings/0001964333-24-000363.md) | [0.4](/filings/0001964333-26-000016.md) | [0.3](/filings/0001964333-25-000180.md) | [0.7](/filings/0001964333-25-000231.md) | [0.5](/filings/0001964333-25-000245.md) | [0.5](/filings/0001964333-26-000095.md) | [0.5](/filings/0001964333-26-000068.md) | [0.5](/filings/0001964333-26-000095.md) |
| Shareholders' equity | $bn | [0.3](/filings/0001964333-24-000363.md) | [0.3](/filings/0001964333-26-000016.md) | [0.3](/filings/0001964333-25-000231.md) | [0.7](/filings/0001964333-25-000245.md) | [0.7](/filings/0001964333-25-000245.md) | [0.7](/filings/0001964333-26-000095.md) | [0.8](/filings/0001964333-26-000095.md) | [0.8](/filings/0001964333-26-000095.md) | [0.8](/filings/0001964333-25-000245.md) | [0.9](/filings/0001964333-26-000095.md) | [0.9](/filings/0001964333-26-000095.md) | [1.2](/filings/0001964333-26-000095.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [9.5 d](/filings/0001964333-24-000363.md) | [10.2 d](/filings/0001964333-26-000016.md) | [7.1](/filings/0001964333-25-000180.md) | [(46.0) d](/filings/0001964333-25-000231.md) | [47.8 d](/filings/0001964333-25-000245.md) | [76.9 d](/filings/0001964333-26-000016.md) | [37.6](/filings/0001964333-26-000068.md) | [0.0 d](/filings/0001964333-26-000095.md) | [39.3 d](/filings/0001964333-25-000245.md) | [30.9 d](/filings/0001964333-26-000016.md) | [26.5](/filings/0001964333-26-000068.md) | [0.3 d](/filings/0001964333-26-000095.md) |
| Capital expenditure | $m | [2.0 d](/filings/0001964333-24-000363.md) | [7.9 d](/filings/0001964333-26-000016.md) | [1.5](/filings/0001964333-25-000180.md) | [1.0 d](/filings/0001964333-25-000231.md) | [1.8 d](/filings/0001964333-25-000245.md) | [0.3 d](/filings/0001964333-26-000016.md) | [1.8](/filings/0001964333-26-000068.md) | [3.4 d](/filings/0001964333-26-000095.md) | [3.9 d](/filings/0001964333-25-000245.md) | [2.6 d](/filings/0001964333-26-000016.md) | [1.9](/filings/0001964333-26-000068.md) | [2.2 d](/filings/0001964333-26-000095.md) |
| Dividends paid | $m | [3.9 d](/filings/0001964333-24-000363.md) | [3.9 d](/filings/0001964333-26-000016.md) | [3.9](/filings/0001964333-25-000180.md) | [8.1 d](/filings/0001964333-25-000231.md) | [8.1 d](/filings/0001964333-25-000245.md) | [8.5 d](/filings/0001964333-26-000016.md) | [8.5](/filings/0001964333-26-000068.md) | [8.5 d](/filings/0001964333-26-000095.md) | [8.5 d](/filings/0001964333-25-000245.md) | [8.5 d](/filings/0001964333-26-000016.md) | [8.5](/filings/0001964333-26-000068.md) | [11.3 d](/filings/0001964333-26-000095.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | period not labelled (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [7.5](/filings/0001964333-23-000213.md) | [7.5](/filings/0001964333-24-000219.md) | [7.5](/filings/0001964333-24-000316.md) | [7.5](/filings/0001964333-24-000363.md) | [7.5](/filings/0001964333-25-000180.md) | [12.2](/filings/0001964333-25-000231.md) | [15.0](/filings/0001964333-25-000245.md) | [15.0](/filings/0001964333-26-000068.md) | [15.0](/filings/0001964333-26-000095.md) | [15.1](/filings/0001964333-25-000245.md) | [15.1](/filings/0001964333-26-000068.md) | [18.5](/filings/0001964333-26-000095.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,187,033 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001964333-26-000095.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.